Aimovig 140 mg in 1 mL Auto-Injector
RxNorm 2120195
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2120195 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Aimovig 140 mg in 1 mL Auto-Injector.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
1 mL Aimovig 140 mg/ML Auto-Injector
(Atom ID: 10828643)
SBDPrescribable
Semantic Branded Drug (SBD):
1 mL erenumab-aooe 140 mg/ML Auto-Injector [Aimovig]
(Atom ID: 10828636)
PSNPrescribable
Prescribable Name (PSN):
Aimovig 140 mg in 1 mL Auto-Injector
(Atom ID: 10828641)
SYPrescribable
Synonym (SY):
Aimovig 140 mg per 1 mL Auto-Injector
(Atom ID: 10828642)
Patient Education
Erenumab-aooe Injection
Erenumab-aooe injection is used to help prevent migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light). Erenumab-aooe injection is in a class of medications called monoclonal antibodies. It works by blocking the action of a certain natural substance in the body that causes migraine headaches.
[Learn More]
* Please review the disclaimer below.